Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2013 Filed May 8, 2013 23:28 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
GrantRestricted Stock Unit · Derivative | 3,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-011727 · doc4.xml · derivative · entry 3 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,335 Underlying: Common Stock · 3,335 shares Expires 2016-05-06 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 06, 2013 Filed May 8, 2013 23:28 UTC |
Canan JohnSr.V-P Finc-Global Controller
|
GrantStock Option (right to buy) · Derivative | 38,647 | $0.00 Strike: $44.98 | $0.00 |
DisclosureSEC source: 0001225208-13-011728 · doc4.xml · derivative · entry 5 Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,647 Underlying: Common Stock · 38,647 shares Expires 2023-05-05 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 6, 2014. Read SEC document |
| May 06, 2013 Filed May 8, 2013 23:28 UTC |
Canan JohnSr.V-P Finc-Global Controller
|
GrantRestricted Stock Unit · Derivative | 4,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-011728 · doc4.xml · derivative · entry 4 Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,002 Underlying: Common Stock · 4,002 shares Expires 2016-05-06 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 06, 2013 Filed May 8, 2013 23:28 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GrantStock Option (right to buy) · Derivative | 644,122 | $0.00 Strike: $44.98 | $0.00 |
DisclosureSEC source: 0001225208-13-011729 · doc4.xml · derivative · entry 4 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 644,122 Underlying: Common Stock · 644,122 shares Expires 2023-05-05 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 6, 2014. Read SEC document |
| May 06, 2013 Filed May 8, 2013 23:28 UTC |
Golestani ClarkEVP & Chief Info Officer
|
GrantStock Option (right to buy) · Derivative | 38,647 | $0.00 Strike: $44.98 | $0.00 |
DisclosureSEC source: 0001225208-13-011730 · doc4.xml · derivative · entry 5 Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,647 Underlying: Common Stock · 38,647 shares Expires 2023-05-05 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 6, 2014. Read SEC document |
| May 06, 2013 Filed May 8, 2013 23:28 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
GrantStock Option (right to buy) · Derivative | 109,501 | $0.00 Strike: $44.98 | $0.00 |
DisclosureSEC source: 0001225208-13-011731 · doc4.xml · derivative · entry 3 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,501 Underlying: Common Stock · 109,501 shares Expires 2023-05-05 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 6, 2014. Read SEC document |
| May 06, 2013 Filed May 8, 2013 23:28 UTC |
KELLOGG PETER NExe V-P & CFO
|
GrantStock Option (right to buy) · Derivative | 206,119 | $0.00 Strike: $44.98 | $0.00 |
DisclosureSEC source: 0001225208-13-011732 · doc4.xml · derivative · entry 3 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,119 Underlying: Common Stock · 206,119 shares Expires 2023-05-05 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 6, 2014. Read SEC document |
| May 06, 2013 Filed May 8, 2013 23:28 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
GrantStock Option (right to buy) · Derivative | 48,309 | $0.00 Strike: $44.98 | $0.00 |
DisclosureSEC source: 0001225208-13-011733 · doc4.xml · derivative · entry 3 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,309 Underlying: Common Stock · 48,309 shares Expires 2023-05-05 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 6, 2014. Read SEC document |
| May 06, 2013 Filed May 8, 2013 23:28 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
GrantStock Option (right to buy) · Derivative | 244,767 | $0.00 Strike: $44.98 | $0.00 |
DisclosureSEC source: 0001225208-13-011734 · doc4.xml · derivative · entry 5 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,767 Underlying: Common Stock · 244,767 shares Expires 2023-05-05 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 6, 2014. Read SEC document |
| May 06, 2013 Filed May 8, 2013 23:29 UTC |
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care
|
GrantStock Option (right to buy) · Derivative | 70,853 | $0.00 Strike: $44.98 | $0.00 |
DisclosureSEC source: 0001225208-13-011735 · doc4.xml · derivative · entry 5 Heller Bridgette P · CIK 0001485616 · Exe.VP & Pres.Con.Hlth.Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,853 Underlying: Common Stock · 70,853 shares Expires 2023-05-05 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 6, 2014. Read SEC document |
| May 06, 2013 Filed May 8, 2013 23:29 UTC |
PERLMUTTER ROGER MExe V-P & Pres, MRL
|
GrantStock Option (right to buy) · Derivative | 225,443 | $0.00 Strike: $44.98 | $0.00 |
DisclosureSEC source: 0001225208-13-011736 · doc4.xml · derivative · entry 3 PERLMUTTER ROGER M · CIK 0001184228 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,443 Underlying: Common Stock · 225,443 shares Expires 2023-05-05 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 6, 2014. Read SEC document |
| May 06, 2013 Filed May 8, 2013 23:29 UTC |
PERLMUTTER ROGER MExe V-P & Pres, MRL
|
GrantRestricted Stock Unit · Derivative | 44,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-011736 · doc4.xml · derivative · entry 2 PERLMUTTER ROGER M · CIK 0001184228 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,464 Underlying: Common Stock · 44,464 shares Expires 2016-05-06 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 06, 2013 Filed May 8, 2013 23:29 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Health
|
GrantStock Option (right to buy) · Derivative | 70,853 | $0.00 Strike: $44.98 | $0.00 |
DisclosureSEC source: 0001225208-13-011737 · doc4.xml · derivative · entry 2 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,853 Underlying: Common Stock · 70,853 shares Expires 2023-05-05 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 6, 2014. Read SEC document |
| May 06, 2013 Filed May 8, 2013 23:29 UTC |
DO CUONG VEVP & Chief Strategy Officer
|
GrantStock Option (right to buy) · Derivative | 64,412 | $0.00 Strike: $44.98 | $0.00 |
DisclosureSEC source: 0001225208-13-011738 · doc4.xml · derivative · entry 1 Do Cuong V · CIK 0001477037 · EVP & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,412 Underlying: Common Stock · 64,412 shares Expires 2023-05-05 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning May 6, 2014. Read SEC document |
| May 06, 2013 Filed May 8, 2013 23:29 UTC |
Holston Michael JEVP, Chief Ethics & Compl Ofcr
|
GrantStock Option (right to buy) · Derivative | 64,412 | $0.00 Strike: $44.98 | $0.00 |
DisclosureSEC source: 0001225208-13-011739 · doc4.xml · derivative · entry 1 Holston Michael J · CIK 0001390613 · EVP, Chief Ethics & Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,412 Underlying: Common Stock · 64,412 shares Expires 2023-05-05 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning May 6, 2014. Read SEC document |
| March 28, 2013 Filed Apr 1, 2013 20:54 UTC |
HARRISON WILLIAM B JRDirector
|
GrantPhantom Stock · Derivative | 820.1357 | $44.20 | $36,250.00 |
DisclosureSEC source: 0001225208-13-008801 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,558.5377 Underlying: Common Stock · 820.1357 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 28, 2013 Filed Apr 1, 2013 20:54 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 565.6109 | $44.20 | $25,000.00 |
DisclosureSEC source: 0001225208-13-008802 · doc4.xml · derivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,339.2029 Underlying: Common Stock · 565.6109 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 28, 2013 Filed Apr 1, 2013 20:54 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 565.6109 | $44.20 | $25,000.00 |
DisclosureSEC source: 0001225208-13-008803 · doc4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,727.4639 Underlying: Common Stock · 565.6109 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 28, 2013 Filed Apr 1, 2013 20:54 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 565.6109 | $44.20 | $25,000.00 |
DisclosureSEC source: 0001225208-13-008804 · doc4.xml · derivative · entry 3 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,928.4879 Underlying: Common Stock · 565.6109 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 25, 2013 Filed Feb 27, 2013 22:50 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
GrantCommon Stock | 2,108 | $42.52 | $89,632.16 |
DisclosureSEC source: 0001225208-13-005759 · doc4.xml · nonDerivative · entry 1 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,442.12 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/2010. Performance shares were paid out at 107 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 25, 2013 Filed Feb 27, 2013 22:50 UTC |
Canan JohnSr.V-P Finc-Global Controller
|
GrantCommon Stock | 2,657 | $42.52 | $112,975.64 |
DisclosureSEC source: 0001225208-13-005760 · doc4.xml · nonDerivative · entry 1 Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,715 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/2010. Performance shares were paid out at 107 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 25, 2013 Filed Feb 27, 2013 22:50 UTC |
Deese Willie AExe V-P & Pres. MMD
|
GrantCommon Stock | 9,567 | $42.52 | $406,788.84 |
DisclosureSEC source: 0001225208-13-005761 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,993.339 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/2010. Performance shares were paid out at 107 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 25, 2013 Filed Feb 27, 2013 22:50 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GrantCommon Stock | 25,484 | $42.52 | $1,083,579.68 |
DisclosureSEC source: 0001225208-13-005762 · doc4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,231.542 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/2010. Performance shares were paid out at 107 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 25, 2013 Filed Feb 27, 2013 22:50 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
GrantCommon Stock | 8,618 | $42.52 | $366,437.36 |
DisclosureSEC source: 0001225208-13-005763 · doc4.xml · nonDerivative · entry 1 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,999.415 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/2010. Performance shares were paid out at 107 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 25, 2013 Filed Feb 27, 2013 22:50 UTC |
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care
|
GrantCommon Stock | 7,174 | $42.52 | $305,038.48 |
DisclosureSEC source: 0001225208-13-005764 · doc4.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Exe.VP & Pres.Con.Hlth.Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,174 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/2010. Performance shares were paid out at 107 percent of target awards. Read SEC document |
| February 25, 2013 Filed Feb 27, 2013 22:50 UTC |
KELLOGG PETER NExe V-P & CFO
|
GrantCommon Stock | 17,178 | $42.52 | $730,408.56 |
DisclosureSEC source: 0001225208-13-005765 · doc4.xml · nonDerivative · entry 1 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,660.902 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/2010. Performance shares were paid out at 107 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 25, 2013 Filed Feb 27, 2013 22:50 UTC |
KIM PETER SExe V-P & Pres, MRL
|
GrantCommon Stock | 18,903 | $42.52 | $803,755.56 |
DisclosureSEC source: 0001225208-13-005766 · doc4.xml · nonDerivative · entry 1 KIM PETER S · CIK 0001181180 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,608.9037 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/2010. Performance shares were paid out at 107 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 25, 2013 Filed Feb 27, 2013 22:50 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
GrantCommon Stock | 12,959 | $42.52 | $551,016.68 |
DisclosureSEC source: 0001225208-13-005767 · doc4.xml · nonDerivative · entry 1 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,556.485 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/2010. Performance shares were paid out at 107 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 25, 2013 Filed Feb 27, 2013 22:50 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
GrantCommon Stock | 5,392 | $42.52 | $229,267.84 |
DisclosureSEC source: 0001225208-13-005768 · doc4.xml · nonDerivative · entry 1 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,776 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/2010. Performance shares were paid out at 107 percent of target awards. Read SEC document |
| February 25, 2013 Filed Feb 27, 2013 22:50 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
GrantCommon Stock | 8,136 | $42.52 | $345,942.72 |
DisclosureSEC source: 0001225208-13-005769 · doc4.xml · nonDerivative · entry 1 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,568 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/2010. Performance shares were paid out at 107 percent of target awards. Read SEC document |
| February 25, 2013 Filed Feb 27, 2013 22:50 UTC |
Golestani ClarkEVP & Chief Info Officer
|
GrantCommon Stock | 1,289 | $42.52 | $54,808.28 |
DisclosureSEC source: 0001225208-13-005770 · doc4.xml · nonDerivative · entry 1 Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,233 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/10. Performance shares were paid out at 107 percent of target awards. Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 22:34 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionRestricted Stock Unit · Derivative | 10,670 | $41.42 | $441,951.40 |
DisclosureSEC source: 0001225208-13-004733 · doc4.xml · derivative · entry 5 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,670 shares Expires 2013-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 22:34 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Tax withholdingCommon Stock | 3,238 | $41.42 | $134,117.96 |
DisclosureSEC source: 0001225208-13-004733 · doc4.xml · nonDerivative · entry 2 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,432 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 22:34 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionCommon Stock | 10,670 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-004733 · doc4.xml · nonDerivative · entry 1 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 22:34 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 15,000 | $41.42 | $621,300.00 |
DisclosureSEC source: 0001225208-13-004734 · doc4.xml · derivative · entry 3 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2013-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 22:34 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
Tax withholdingCommon Stock | 5,616 | $41.42 | $232,614.72 |
DisclosureSEC source: 0001225208-13-004734 · doc4.xml · nonDerivative · entry 2 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,384 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 22:34 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
Exercise / conversionCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-004734 · doc4.xml · nonDerivative · entry 1 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2012 Filed Jan 3, 2013 15:47 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 610.6497 | $40.94 | $25,000.00 |
DisclosureSEC source: 0001225208-13-000330 · doc4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,702.1717 Underlying: Common Stock · 610.6497 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2012 Filed Jan 3, 2013 15:47 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 610.6497 | $40.94 | $25,000.00 |
DisclosureSEC source: 0001225208-13-000331 · doc4.xml · derivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,327.9207 Underlying: Common Stock · 610.6497 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2012 Filed Jan 3, 2013 15:47 UTC |
HARRISON WILLIAM B JRDirector
|
GrantPhantom Stock · Derivative | 885.4421 | $40.94 | $36,250.00 |
DisclosureSEC source: 0001225208-13-000332 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,205.0341 Underlying: Common Stock · 885.4421 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2012 Filed Jan 3, 2013 15:47 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 610.6497 | $40.94 | $25,000.00 |
DisclosureSEC source: 0001225208-13-000333 · doc4.xml · derivative · entry 4 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,951.6247 Underlying: Common Stock · 610.6497 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| November 12, 2012 Filed Nov 13, 2012 20:05 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $32.72 | $0.00 |
DisclosureSEC source: 0001225208-12-022965 · doc4.xml · derivative · entry 9 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2015-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2012 Filed Nov 13, 2012 20:05 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $23.45 | $0.00 |
DisclosureSEC source: 0001225208-12-022965 · doc4.xml · derivative · entry 8 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,800 Underlying: Common Stock · 30,000 shares Expires 2019-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2012 Filed Nov 13, 2012 20:05 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,880 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001225208-12-022965 · doc4.xml · derivative · entry 7 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,880 shares Expires 2016-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2012 Filed Nov 13, 2012 20:05 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 500 | $0.00 Strike: $34.47 | $0.00 |
DisclosureSEC source: 0001225208-12-022965 · doc4.xml · derivative · entry 6 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2016-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2012 Filed Nov 13, 2012 20:05 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
SaleCommon Stock | 61,380 | $44.02 | $2,702,045.81 |
DisclosureSEC source: 0001225208-12-022965 · doc4.xml · nonDerivative · entry 5 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,808.016 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.9900 to $44.0550, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| November 12, 2012 Filed Nov 13, 2012 20:05 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionCommon Stock | 500 | $34.47 | $17,235.00 |
DisclosureSEC source: 0001225208-12-022965 · doc4.xml · nonDerivative · entry 4 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,188.016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2012 Filed Nov 13, 2012 20:05 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionCommon Stock | 10,000 | $32.72 | $327,200.00 |
DisclosureSEC source: 0001225208-12-022965 · doc4.xml · nonDerivative · entry 3 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,688.016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2012 Filed Nov 13, 2012 20:05 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionCommon Stock | 20,880 | $35.09 | $732,679.20 |
DisclosureSEC source: 0001225208-12-022965 · doc4.xml · nonDerivative · entry 2 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,688.016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2012 Filed Nov 13, 2012 20:05 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionCommon Stock | 30,000 | $23.45 | $703,500.00 |
DisclosureSEC source: 0001225208-12-022965 · doc4.xml · nonDerivative · entry 1 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,808.016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.